Related Experiment Video
Updated: Jul 18, 2026
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Appraising adjuvant aromatase inhibitor therapy
1Mayo Clinic, Jacksonville, Florida 32224, USA. perez.edith@mayo.edu
The Oncologist
|November 18, 2006
Summary
Third-generation aromatase inhibitors (AIs) offer improved survival over tamoxifen for early breast cancer. AIs have manageable side effects, making them a cost-effective alternative for individualized endocrine therapy.
Area of Science:
- Oncology
- Endocrinology
- Pharmacology
Background:
- Tamoxifen was the standard adjuvant endocrine therapy for early breast cancer.
- Third-generation aromatase inhibitors (AIs) now demonstrate improved disease-free survival.
- Tamoxifen and AIs have distinct safety profiles, enabling personalized treatment.
Purpose of the Study:
- To compare the efficacy and safety of tamoxifen and third-generation aromatase inhibitors (AIs) in early breast cancer.
- To inform individualized treatment decisions based on patient comorbidities and risk factors.
- To evaluate the cost-effectiveness of AIs versus tamoxifen.
Main Methods:
- Review of clinical trial data comparing tamoxifen and AIs.
- Analysis of safety profiles, including effects on bone health, cardiovascular events, and endometrial cancer.
- Assessment of disease-free survival rates and cost-effectiveness.
Main Results:
- Aromatase inhibitors (AIs) show improved disease-free survival compared to tamoxifen.
- Tamoxifen has benefits for lipids and bone health but increases risks of endometrial cancer and thromboembolic events.
- AIs' primary side effect is bone loss, potentially increasing fracture risk.
Conclusions:
- Aromatase inhibitors (AIs) are a cost-effective and efficacious alternative to tamoxifen for adjuvant therapy in hormone-sensitive early breast cancer.
- Clinical guidelines recommend AIs for appropriate patients.
- Ongoing trials will further clarify long-term AI safety and applications.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications